Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration-Reference-Cited by-同舟云学术

Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration

Published:2015-08 Issue:32 Volume:290 Page:19433-19444
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Daher João P.L.,Abdelmotilib Hisham A.,Hu Xianzhen,Volpicelli-Daley Laura A.,Moehle Mark S.,Fraser Kyle B.,Needle Elie,Chen Yi,Steyn Stefanus J.,Galatsis Paul,Hirst Warren D.,West Andrew B.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. The prevalence of Parkinson's disease: a systematic review and meta-analysis;Pringsheim;Movement Disorders,2014

2. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol. Aging,2003

3. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease;Nalls;Nat. Genet,2014

4. α-Synuclein locus triplication causes Parkinson's disease;Singleton;Science,2003

5. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study;Healy;Lancet Neurol,2008

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AAV-α-Synuclein Model of Parkinson’s Disease: An Update;Journal of Parkinson's Disease;2024-09-03

2. LRRK2 Kinase Inhibitor PF-06447475 Protects Drosophila melanogaster against Paraquat-Induced Locomotor Impairment, Life Span Reduction, and Oxidative Stress;Neurochemical Research;2024-06-07

3. LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease;Journal of Cellular Physiology;2024-03-13

4. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice;npj Parkinson's Disease;2023-12-18

5. Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson’s disease;Bioorganic Chemistry;2023-12